710 research outputs found

    An integrated knowledge translation experience: Use of the Network of Pediatric Audiologists of Canada to facilitate the development of The University of Western Ontario Pediatric Audiological Monitoring Protocol (UWO PedAMP v1.0).

    Get PDF
    The goals of this project were: (1) to determine the important factors that influence implementation of evidence-based practice by Canadian audiologists; and (2) to utilize the knowledge-to-action process (Graham et al., 2006) during the development of a guideline for outcome measures to evaluate the auditory development and performance of young children who wear hearing aids, to facilitate clinical uptake and identify barriers to implementation (Bagatto, Moodie & Scollie, 2010; Bagatto et al., 2011; Bagatto, Moodie, Seewald, Bartlett, & Scollie, 2011; Moodie, Bagatto et al., 2011; Moodie, Kothari et al., 2011). Two projects (Chapters 3 and 4) included the participation of The Network of Pediatric Audiologists of Canada. The outcome measures guideline to evaluate the auditory development and performance of young children who wear hearing aids is called The University of Western Ontario Pediatric Audiological Monitoring Protocol (UWO PedAMP). This body of work includes a chapter on knowledge translation and how it can be used to promote the clinical implementation of evidence in audiology (Chapter 3). It also includes three studies: (1) an examination of factors influencing the use of evidence by Canadian audiologists [Chapter 2]; (2) an initial evaluation by the Network of Pediatric Audiologists of Canada of the individual components considered for inclusion in the UWO PedAMP [Chapter 4]; and (3) a final evaluation by the Network audiologists of the released version of the UWO PedAMP and associated training materials [Chapter 5]. Results of the first study indicated that Canadian audiologists rate themselves as competent in finding, evaluating and using research evidence to change practice. Their greatest barriers to evidence-based practice are related to time. By partnering with Canadian audiologists and using the knowledge-to-action framework to guide us (Chapter 4), we were successful in developing the UWO PedAMP guideline into what they rated as being a high-quality, systematic, hearing aid outcome evaluation tool that improves the quality and effectiveness of audiological care received by young children with hearing loss. The results presented in Chapter 5 indicated that the UWO PedAMP is appropriate for clinical implementation, and is recommended by these Canadian audiologists as preferred audiology practice

    Fast track children's hearing pilot: final report of the evaluation of the pilot

    Get PDF
    This report presents key findings of the evaluation of the Fast Track children’s hearings pilot in Scotland1. The research was undertaken by staff at the Universities of Glasgow, Stirling and Strathclyde between February 2003 and January 2005

    In situ GISAXS study of the growth of Pd on MgO(001)

    Full text link
    The morphology of growing Pd nano-particles on MgO(001) surfaces have been investigated in situ, during growth, by grazing incidence small angle x-ray scattering, for different substrate temperatures. The 2D patterns obtained are quantitatively analyzed, and the average morphological parameters (shape, size) deduced. Above 650 K, the aggregates adopt their equilibrium shape of truncated octahedron, and the interfacial energy is deduced.Comment: 10 pages, 1 Table, 2 Figure

    Use of cigarettes with flavor-changing capsules among smokers in the United Kingdom: An online survey

    Get PDF
    Introduction Cigarettes with flavour-changing capsules in the filter have experienced phenomenal global growth in the last decade. We explore socio-demographic and smoking-related factors associated with using capsule cigarettes, how frequently users burst the capsule, and reasons for using them. Methods An online survey was conducted in the United Kingdom between April-May 2016 with 6234 factory-made and/or hand-rolled cigarette smokers. This analysis focuses on 3620 factory-made cigarette smokers, aged 18 years and over, who had smoked in the past month. Results Thirteen percent smoked capsule cigarettes, with younger smokers more likely than older smokers to do so. Capsule use was significantly more common among white non-British than white British, and among those planning to quit in the next six months than those not planning to quit. Most capsule users who crushed the capsule did so always (51%) or most of the time (18%), with more frequent crushing of capsules more common among females, younger and middle-aged participants, white-British and those with a lower score on the Heaviness of Smoking Index. The most common reasons for using capsule cigarettes were that they taste better (52%), are smoother (41%), provide a choice of flavours (32%) and the enjoyment of clicking the capsule (25%). Capsule and non-capsule smokers did not differ significantly in their perceptions of the harmfulness of their brand relative to other brands. Conclusions Our study provides an insight into how and why smokers of capsule cigarettes use these products, with the key drivers of use being taste, flavour choice and interactivity

    Flavour capsule cigarettes continue to experience strong global growth

    Get PDF
    First paragraph: Cigarettes with flavour-changing capsules in the filter, a continuing success story for tobacco companies, have grown exponentially since being introduced in 2007. The global capsule market is estimated to be 150 billion sticks in 2017. We provide an update on the capsule market since 2014. From this time capsule cigarettes have been introduced in new markets in Europe (Croatia, Spain), Africa (Tunisia), Latin America (Bolivia, Ecuador, Uruguay) and Asia (China, India, Philippines, Thailand, Vietnam). They are the fastest growing segment of the combustible market, with market share increasing between 2014 and 2017 in 52 of the 67 countries where they are sold and monitored by tobacco analyst Euromonitor. These products now have market share greater than 10% in four European countries (UK, Hungary, Ireland, Poland), and have increased 12% in the Middle East and Africa. The five most popular capsule markets remain in Latin America (see Figure 1), with market share increasing by at least 40% in each of these countries since 2014

    The Power of Product Innovation: Smokers' Perceptions of Capsule Cigarettes

    Get PDF
    Introduction  Since being brought to market in 2007, cigarettes with capsules in the filter that can be burst to change the flavor have had remarkable global success, highlighting the importance of product innovation for tobacco companies. Very few studies have explored how these products are perceived by smokers however. This paper sought to address this gap by exploring smokers’ awareness of cigarettes with one or two flavor-changing capsules in the filter and the appeal of these products.  Methods  Twenty focus groups were conducted in Glasgow and Edinburgh in 2015 with current smokers (N= 120), segmented by age (16–17, 18–24, 25–35, 36–50, >50), gender, and social grade.  Results  Awareness, use and appeal of capsule cigarettes was greater among younger adults (16–35 years), who showed most interest in these products. Those who perceived capsules positively mentioned multiple benefits: the ability to burst the capsule, convenience of being able to share cigarettes among menthol and nonmenthol smokers, better taste, fresher breath, reduced smell, and greater discretion. It was suggested that capsule cigarettes, particularly the double capsule cigarette (which had two differently flavored capsules in the filter), would encourage nonsmokers to experiment with smoking and discourage smokers from quitting.  Conclusions  The findings offer some reasons behind the global growth of the capsule cigarette segment.  Implications  Cigarettes with flavor-changing capsules in the filter have been one of the most successful product innovations of the last decade for tobacco companies. They have received very little academic attention however. Employing focus groups with 120 smokers aged 16 and over, we found that capsule cigarettes held most appeal to, and were considered to be targeted at, younger people, with it suggested that these products would encourage initiation and discourage cessation. This study provides some understanding of how these products are viewed by smokers

    I-The Point Source

    Get PDF

    Photonically enabled communication systems beyond 1000 GHz

    Get PDF
    This paper presents a review of the recent development and research work on InP devices and their associated systems to generate and detect signal beyond 1 THz. The potential of the technology and the remaining challenges are also discussed. The paper will present recent results on laser sources that could be used as the basis of the THz sources as well as a set of potential THz emitters such as the UTC photodiode which has already permitted up to 25 muW to be emitted at 1 THz

    Gambling with the future of young people

    Get PDF
    First paragraph: UK Policy makers addressed two key public health problems last summer: smoking and gambling. Both are quasi-voluntary behaviours, involve powerful vested interests and have serious implications for the future health and well being of young people; but policy on them is going in opposite directions. July’s smokefree legislation was followed in October by a law increasing the legal age of tobacco purchase to 18. This builds on the 2002 Tobacco Advertising and Promotion Act, which removed all tobacco advertising, and the mandating of enhanced health warnings in 2001, which in October 2008 will be further improved by the addition of graphic images. These measures combine with systematic increases in the taxation on tobacco products, NHS countrywide smoking cessation services and multi-component health promotion

    The Cross-Sectional Association between Diet Quality and Depressive Symptomology amongst Fijian Adolescents

    Get PDF
    OBJECTIVE: To examine the relationship between diet quality and depressive symptomology amongst a community-based sample of Fijian adolescents. METHODS: Participants included 7,237 adolescents (52.6% girls; mean age 15.6 years) at baseline (2005) and 2,948 (56% girls; mean age 17.4 years) at follow-up (2007/2008), from the Pacific Obesity Prevention in Communities Project. Intervention schools (n = 7) were selected from Nasinu, near Suva on the main Fijian island Viti Levu, and comparison schools (n = 11) were chosen from towns on the opposite, west side of the island. A dietary questionnaire was used to measure diet quality. Factor analysis clustered dietary variables into two unique and independent factors, referred to as healthy diet quality and unhealthy diet quality. Depressive symptomology was assessed via the emotional subscale of the Paediatric Quality of Life Inventory. Both measures were self-reported and self-administered. Multiple linear regression was used to test cross-sectional associations (at baseline and follow-up) between diet quality and depressive symptomology. Variables controlled for included gender, age, ethnicity, study condition, BMI-z scores, and physical activity. FINDINGS: Strong, positive dose-response associations between healthy diet and high emotional scores (lower depressive symptomology) were found in cross-sectional analyses at baseline and follow-up, among boys and girls. No association was found between emotional health and unhealthy diet. CONCLUSIONS: This study suggests that cross-sectional relationships exist between a high quality diet during adolescence and less depressive symptoms, however more evidence is required to determine if these two variables are linked causally. Trial population health strategies that use dietary interventions as a mechanism for mental health promotion provide an opportunity to further test these associations. If this is indeed a true relationship, these forms of interventions have the potential to be inexpensive and have substantial reach, especially in Low and Middle Income Countries. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12608000345381
    • …
    corecore